How Confident Are You in Precision Oncology? Take This 10-Minute Survey

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition

Grand Rounds by OncoDaily: AI in Oncology Edition

How I Treat Bladder Cancer in 2026: OncoDaily Virtual Summit

Head and Neck Cancer Awareness Month 2026: The Urgency of Early Diagnosis in Modern Oncology

Oncology News, Insights, Stories by OncoDaily

How I Treat Head and Neck Cancers
OncoDaily

How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

OncoDiscovery
OncoDaily Pulse

OncoDiscovery Award - A New Short-Term Funding Opportunity for Early-Career Medical Oncologists Around the World

OncoDaily at ASCO 2026
OncoDaily Pulse

OncoDaily at ASCO 2026

Immunotherapy in Oncology (2025–2026): FDA Approvals and NCCN Evidence

Paco Arango: A Little Piece of What Will be the Casa Aladina

Matthias Guckenberger: Clinical Trial Endpoints for Metastases Directed Therapy in Oligometastatic Cancer

Eli Lilly Moves Boldly into Next-Generation Blood Cancer with $2.3B Ajax Therapeutics Acquisition

Shushan Hovsepyan: This Year Sarcomas Will Be Louder at ASCO

David Collingridge: Join The Lancet Oncology Session on "Women, Power and Cancer" at IARC60

Pimurutamab (HLX07) + Serplulimab + Chemotherapy Completes CTN in Australia

Voices
Miriam Mutebi

Miriam Mutebi: Emmanuel Lomole Wins the "Most Influential" Policy Award in Kenya

Sumanta K. Pal: Implementing AI in Clinical Practice to Help Maintain The Decision-Making Agility

Wafik S. El-Deiry: Seeding Density–Dependent Drug Resistance Measured by ISDS Index

Ruthresh Rao Subramanyan: Shaping the Future of Preventive Healthcare with AI in a Powerful Room

Strengthening Collaboration and Innovation in Healthcare at IUCC 2026

How Confident Are You in Precision Oncology? Take This 10-Minute Survey

Bringing Together Passionate Advocates From Across the Europa Donna Network

FDA Approvals
Tecartus

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

Aktis Advances Radiopharmaceutical Pipeline With AKY-2519 FDA Clearance

FDA Grants Full Approval of BRAFTOVI Combination Regimen in 1L Metastatic Colorectal Cancer

FDA Approves Combination Treatment of VENCLEXTA (venetoclax) and Acalabrutinib for Previously Untreated Patients With CLL

Monthly RYBREVANT FASPRO (Amivantamab) Approved by FDA for EGFR-Mutated NSCLC

PANOVA-3 Leads to FDA Approval of Optune Pax in Locally Advanced Pancreatic Cancer

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

NCCN 2026 Policy Summit: Innovations in Cancer Care Through the Ages

The National Comprehensive Cancer Network

25 Jun
NCCN

NCCN 2026 Policy Summit: Health Literacy in the Cancer Care Digital Age

The National Comprehensive Cancer Network

07 May
NCCN

NCCN Webinar Series - Treatment Options for Richter Transformation of Chronic Lymphocytic Leukemia

The National Comprehensive Cancer Network

06 May
Chronic Lymphocytic Leukemia

NCCN Global Policy Webinar - The Growing Cancer Burden in Young Adults

NCCN

21 May
NCCN

How I Treat Head and Neck Cancers in 2026: OncoDaily Virtual Summit

OncoDaily

30 Apr
Head and Neck Cancers

Immune-oncology
Immunotherapy in Oncology (2025–2026): FDA Approvals and NCCN Evidence

Immunotherapy in Oncology (2025–2026): FDA Approvals and NCCN Evidence

Pimurutamab (HLX07) + Serplulimab + Chemotherapy Completes CTN in Australia

Top Immunotherapy Trials to Watch at ASCO 2026

10 Must-Read Posts in Immuno-Oncology This Week

FDA Priority Review: Pembrolizumab + Enfortumab Vedotin for Cisplatin-Eligible MIBC

innovaTV Trial Update: Tisotumab Vedotin in Cervical Cancer

Spatial Omics for Characterizing the Dynamic Tumor Microenvironment

Gastrointestinal-Oncology
BBOpCo at AACR 2026

BBOpCo at AACR 2026: First-Line BOT/BAL in Selected MSS Colorectal Cancer Population

Promising Phase I Results for BOT/BAL and agenT-797 in PD-1 Refractory Gastroesophageal Cancer

10 Must-Read Posts In GI Oncology This Week

Phase II LEAP-005 Results: Lenvatinib plus Pembrolizumab in Pretreated GI Cancers

ESMO 2026 Guideline: Redefining the Management of Metastatic Colorectal Cancer

Immunotherapy in GI Cancers 2026: From Expansion to Precision

Phase 3 RASolute 302 Trial: Daraxonrasib Improves Overall Survival in Metastatic Pancreatic Cancer

Breast-Oncology
Camizestrant

AstraZeneca’s Camizestrant Faces FDA ODAC Review In ESR1-Mutated HR+/HER2− Breast Cancer

After CDK4/6 Inhibitors: How Oral SERDs Are Reshaping HR+/HER2− Metastatic Breast Cancer

Updates In HER2-Low Breast Cancer Treatment Strategies

Top 10 Breast Cancer Abstracts To Watch At ESMO Breast Cancer 2026

PIK3CA Testing in Advanced HR+/HER2- Breast Cancer: New Expert Consensus Defines a Practical Path Forward

PREDICT sTILs: Bringing Immune Biology Into Chemotherapy Decisions for TNBC

Breast Cancer This Week: 10 Updates You Should Not Miss In April 13 to 20, 2026

Lung-Oncology
Osimertinib

Osimertinib After Chemoradiotherapy in Stage III EGFR-Mutated NSCLC: LAURA Redefines the Standard of Care

KIRHub Opens A New Repurposing Map For Kinase Inhibitors In Lung Cancer

Ifinatamab Deruxtecan Receives FDA Priority Review In Previously Treated ES-SCLC

LAT Plus EGFR TKIs In Advanced EGFR+ NSCLC: A New Multimodality Signal

Tumor-Draining Lymph Nodes in NSCLC: The Underused Frontier in Biomarker Discovery and Therapeutic Innovation

MATISSE Trial Suggests CD39 Blockade May Deepen Pathologic Response in Resectable NSCLC

ASCO 2026 Lung Cancer Preview: Key Trials With Practice-Changing Potential

OncoDaily TV
Journey from Botswana South Africa

A Journey from Botswana to the Frontlines of Global Health Leadership։ Shenaaz El Halabi

Giuseppe Caruso SGO 2026 Congress Highlights

SGO 2026 Congress Highlights: ADCs Dominate Gynecologic Oncology – Key Takeaways with Giuseppe Caruso

RichardGoldberg

Miles to Go Before We Sleep — Dr. Richard Goldberg on Curing Colorectal Cancer

A new partnership to take cancer vaccines from research to care - with Karen Knudsen and Kristen Dahlgren

A new partnership to take cancer vaccines from research to care – with Karen Knudsen and Kristen Dahlgren

Bringing Cancer Knowledge to Every Corner: How eCancer Delivers Free Education Worldwide

Bringing Cancer Knowledge to Every Corner: How eCancer Delivers Free Education Worldwide

Noetic Medicine: The Science Behind Healing Through Words

Noetic Medicine: The Science Behind Healing Through Words

Empowering Oncologists: How Do We Apply Training, Research And Best Practices to Low Resource Settings

Empowering Oncologists: How Do We Apply Training, Research And Best Practices to Low Resource Settings

Precision at the Core: Advancing Nasopharyngeal Carcinoma Care with Proton Beam Therapy - Episode 1

Precision at the Core: Advancing Nasopharyngeal Carcinoma Care with Proton Beam Therapy – Episode 1

ACT for Children Initiative: Making a Durable Change

ACT for Children Initiative: Making a Durable Change

Bridging the Gap: Sustainable Cancer Care in Low and Middle Income Countries

Bridging the Gap: Sustainable Cancer Care in Low and Middle Income Countries

Ensuring equitable access to cancer care worldwide

Ensuring equitable access to cancer care worldwide: Pat Garcia-Gonzalez

How to Publish High-Impact Research in Top Journals

How to Publish High-Impact Research in Top Journals: Gustavo Monnerat

Not To Miss
head and neck awareness - OncoDaily

Head and Neck Cancer Awareness Month 2026: The Urgency of Early Diagnosis in Modern Oncology

SGO 2026 Congress Highlights: ADCs Dominate Gynecologic Oncology - Key Takeaways with Giuseppe Caruso

20 Posts Not To Miss From Lung Cancer Europe 2026 Conference

Recognition of Gratitude - ISCO 2026 Congress

Highlights From Myelo 2026: Virtual Global Myeloma Congress

Introducing the Chairs at ISCO Congress 2026 - Part 2

Introducing the Chairs at ISCO Congress 2026 - Part 1

OncoGrants
Prostate Cancer

Prostate Cancer Foundation Canada 2026 Grant-in-Aid Awards

Prostate Cancer UK 2026 Career Acceleration Fellowships

DoD FY26 Prostate Cancer Research Programs

DoD FY26 Prostate Cancer Research Programs

UCSF Prostate Cancer SPORE 2026 Career Enhancement Program (CEP) Award

UCSF Prostate Cancer SPORE 2026 Career Enhancement Program (CEP) Award

UCSF Prostate Cancer SPORE 2026 Developmental Research Program (DRP) Award

UCSF Prostate Cancer SPORE 2026 Developmental Research Program (DRP) Award

Prostate Cancer Research (UK Charity) Patient and Public Involvement (PPI) Seed Grant

Prostate Cancer Research (UK Charity) Patient and Public Involvement (PPI) Seed Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
AML

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

CancerWorld

Oncologists
Mohamed Emam Sobeih

Mohamed Emam Sobeih

Oncologists Location Giza, Egypt
Robert E. Reiter

Robert E. Reiter

Oncologists Location Los Angeles, USA
Amalya Sargsyan

Amalya Sargsyan

Oncologists Location Yerevan, Armenia
Luciano Mutti

Luciano Mutti

Oncologists Location L’Aquila, Italy
Antonio Lázaro Sánchez

Antonio Lázaro Sánchez

Oncologists Location El Palmar, Spain
Zulfiquer Otty

Zulfiquer Otty

Oncologists Location Townsville, Australia
Dinesh Pendharkar

Dinesh Pendharkar

Oncologists Location Faridabad, India
Imène Hadji

Imène Hadji

Oncologists Location Guelma, Algeria

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OrigAMI-1 Trial

OrigAMI-1 Trial: Amivantamab in Refractory Metastatic Colorectal Cancer

Drug Discovery

Human-Centric New Approach Methodologies in Drug Discovery

PROOF 301

PROOF 301 Trial: Infigratinib vs Gemcitabine/Cisplatin in FGFR2-Rearranged Cholangiocarcinoma

ROSELLA Trial

The ROSELLA trial: Relacorilant + Nab-Paclitaxel Improves Survival in Platinum-Resistant Ovarian Cancer

Bi-Specific T cell

Bi-Specific T Cell Engagers in Cancer Therapy: Mechanisms, Advances, and Clinical Impact

OncoDaily Medical Journal

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0310-6131

Prevalence and Associated Factors of Cholelithiasis in Pediatric Sickle Cell Disease Patients at Qatif Health Network, Saudi Arabia
Original Research

Precision Oncology

10.69690/ODMJ-002-0226-7267

Unlocking Precision Medicine in Multiple Myeloma: Venetoclax and Novel Targeted Therapies
Review

Oncology Nursing

10.69690/ODMJ-002-0204-6423

Extracorporeal membrane oxygenation in the management of oncologic critical illness
Review